Vanderbilt to Lead $4M PGx Project to Identify HIV Drug Response Markers | GenomeWeb
NEW YORK (GenomeWeb News) – The National Institute of Allergy and Infectious Diseases has granted just over $4 million to a Vanderbilt University-led study to identify genetic variations that may predict how individuals will respond to HIV therapies.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.